In vivo Principal Scientist Cardio-Renal Pharmacology

Novo Nordisk is building a world-class research team within Cardio-Renal Disease Research and is seeking an experienced and highly motivated scientist to drive our efforts in the discovery of novel therapeutic molecules with focus on Chronic Kidney Disease (CKD). Are you a scientist ready to drive breakthroughs in drug discovery for CKD? Are you interested in taking the lead in driving the transformation of innovative research ideas into treatments that save lives? Then, join our global project team at Novo Nordisk Research & Development, where you'll shape the future of early drug discovery. The job level for In vivo Scientist Cardio-Renal Pharmacology is commensurate with individual experience level and qualification of a suitable candidate. The position You will contribute to innovation by identifying and evaluation of new therapeutic agents for the treatment of CKD through target identification, validation, and pre-clinical evaluation of novel treatment options. The role will require scientific leadership within kidney disease and participation in global project teams in close collaboration with experts in other areas such as in vitro biology, chemistry, formulations, histology, and bioanalysis. Depending on your seniority, you will be guiding 1-2 laboratory technicians. Your responsibilities include planning and executing in vivo studies, data analysis, interpreting of data, and recommendations for next steps to project teams and senior leadership. You will interact with external research collaborators in both academic and industry settings, attend scientific conferences, and publish in scientific journals. This role requires an outside travel of 0-10%. Qualifications As an expert within CKD you will have hands on experience with preclinical in vivo kidney models with focus on progressive injuries in glomeruli, tubules, interstitium and/or vasculature, as well as disease-specific mechanisms of inflammation, fibrosis and human translational relevance of such models. You hold a PhD in life sciences with at least 2 years of postdoctoral experience, a proven track record of publications in scientific journals, as well as a strong scientific network within the field of renal disease. Industry experience, knowledge of pharmacology and/or drug discovery principles and/or experience with preclinical models of cardiovascular disease is an asset. You are a dedicated, open-minded, and innovative team player with good collaboration and problem-solving skills. You enjoy working in cross-disciplinary teams and independently on multiple programs in a fast-paced environment. Proficiency in spoken and written English is required. About the department The department consists of 11 employees of whom 4 are Research Scientists on various levels. Måløv is the largest research center of Novo Nordisk, a site for innovation, idea generation, and preclinical testing of medicine candidates across our therapy areas. The research site is a vibrant, inclusive workplace hosting scientists, post-docs, PhD students, research assistants and technicians and has an international work environment. Our research and discovery units across China, Denmark, the United Kingdom and the United States are designed to provide the best scientific environment for the discovery and development of breakthrough therapies. Join us and make a difference. International candidates are encouraged to apply. Contact For further information, please contact Adam Chambers, Department manager Cardio-Renal Pharmacology at +459192 9730. Deadline 21 June 2023 Please note that applications will be reviewed continuously, thus the advert may close prior to the indicated deadline. You do not need to attach a cover letter to your application but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.